Evidence map›Paper›PMID 33206642›Full record

ArticlePloS one2020

Oxidative stress-induced inflammation in susceptible airways by anthropogenic aerosol.

Zaira Leni, Laure Estelle Cassagnes, Kaspar R Daellenbach, Imad El Haddad, Athanasia Vlachou, Gaelle Uzu, André S H Prévôt, Jean-Luc Jaffrezo, Nathalie Baumlin, Matthias Salathe and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Prenatal Exposure toEnvironmental health perspectives · 2023
    Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Zaira LeniInstitute of Anatomy, University of Bern, Bern, Switzerland.ORCID 0000-0001-6794-1727
Laure Estelle CassagnesLaboratory of Atmospheric Chemistry, Paul Scherrer Institute, Villigen, Switzerland.
Kaspar R DaellenbachLaboratory of Atmospheric Chemistry, Paul Scherrer Institute, Villigen, Switzerland.
Imad El HaddadLaboratory of Atmospheric Chemistry, Paul Scherrer Institute, Villigen, Switzerland.
Athanasia VlachouLaboratory of Atmospheric Chemistry, Paul Scherrer Institute, Villigen, Switzerland.
Gaelle UzuUniv. Grenoble Alpes, CNRS, IRD, INP, IGE, Grenoble, France.ORCID 0000-0002-7720-0233
André S H PrévôtLaboratory of Atmospheric Chemistry, Paul Scherrer Institute, Villigen, Switzerland.
Jean-Luc JaffrezoUniv. Grenoble Alpes, CNRS, IRD, INP, IGE, Grenoble, France.
Nathalie BaumlinDepartment of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, United States of America.
Matthias SalatheDepartment of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, United States of America.
Urs BaltenspergerLaboratory of Atmospheric Chemistry, Paul Scherrer Institute, Villigen, Switzerland.
Josef DommenLaboratory of Atmospheric Chemistry, Paul Scherrer Institute, Villigen, Switzerland.ORCID 0000-0002-0006-0009
Marianne GeiserInstitute of Anatomy, University of Bern, Bern, Switzerland.ORCID 0000-0002-4288-7995
Paul Scherrer Institute · CHInstitut polytechnique de Grenoble · FRUniversity of Bern · CHUniversity of Kansas Medical Center · US

Funding

Anti-inflammatory therapy to augment CFTR rescue in CF patientsR01HL133240 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SALATHE, MATTHIAS A · 2017 to 2020
$2.7M
TRP-mediated airway inflammation by e-cigarette vapingR01HL139365 · NHLBI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SALATHE, MATTHIAS A · 2018 to 2021
$1.8M
NHLBI NIH HHS R01 HL133240NHLBI NIH HHS R01 HL139365
6 · The paper itself

Abstract

Ambient air pollution is one of the leading five health risks worldwide. One of the most harmful air pollutants is particulate matter (PM), which has different physical characteristics (particle size and number, surface area and morphology) and a highly complex and variable chemical composition. Our goal was first to comparatively assess the effects of exposure to PM regarding cytotoxicity, release of pro-inflammatory mediators and gene expression in human bronchial epithelia (HBE) reflecting normal and compromised health status. Second, we aimed at evaluating the impact of various PM components from anthropogenic and biogenic sources on the cellular responses. Air-liquid interface (ALI) cultures of fully differentiated HBE derived from normal and cystic fibrosis (CF) donor lungs were exposed at the apical cell surface to water-soluble PM filter extracts for 4 h. The particle dose deposited on cells was 0.9-2.5 and 8.8-25.4 μg per cm2 of cell culture area for low and high PM doses, respectively. Both normal and CF HBE show a clear dose-response relationship with increasing cytotoxicity at higher PM concentrations. The concurrently enhanced release of pro-inflammatory mediators at higher PM exposure levels links cytotoxicity to inflammatory processes. Further, the PM exposure deregulates genes involved in oxidative stress and inflammatory pathways leading to an imbalance of the antioxidant system. Moreover, we identify compromised defense against PM in CF epithelia promoting exacerbation and aggravation of disease. We also demonstrate that the adverse health outcome induced by PM exposure in normal and particularly in susceptible bronchial epithelia is magnified by anthropogenic PM components. Thus, including health-relevant PM components in regulatory guidelines will result in substantial human health benefits and improve protection of the vulnerable population.

Indexed as

Oxidative StressAerosolsAir PollutantsCells, CulturedCystic FibrosisEpithelial CellsHumansInflammationInflammation MediatorsParticle SizeParticulate MatterRespiratory MucosaAerosolsAir PollutantsInflammation MediatorsParticulate Matter

Identifiers

PMID33206642
PMCPMC7673561
OpenAlexW3106108271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.